Journals / Turkish Journal of Gastroenterology / 2015 / Cilt: 26 - Sayı: 3

Prevalence of Barrett's esophagus in Lebanon

Pages
214–217
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The reasons for this East-West divide are unknown and require further investigation.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/Aims: To determine the prevalence of Barrett s Esophagus (BE) in a tertiary care center in Lebanon and to compare IT with regional and global data.
📊
Key Findings & Data:Materials and Methods: All esophagogastroduodenoscopies (EGDs) performed between January 2003 and Octo- ber 2013 at the American University of Beirut Medical Center (AUBMC) were reviewed, and cases of endoscopically suspected esophageal metaplasia (ESEM) were identified.
💡
Conclusion & Impact:The reasons for this East-West divide are unknown and require further investigation.
🔬Design:Review & Systematic Survey
📍Scope:2003 Verileri
⚙️Variables:Domain Parameters

Abstract

Background/Aims: To determine the prevalence of Barrett s Esophagus (BE) in a tertiary care center in Lebanon and to compare IT with regional and global data. Materials and Methods: All esophagogastroduodenoscopies (EGDs) performed between January 2003 and Octo- ber 2013 at the American University of Beirut Medical Center (AUBMC) were reviewed, and cases of endoscopically suspected esophageal metaplasia (ESEM) were identified. Definite BE was considered only if histologically proven intestinal metaplasia was present. Results: Totally, 16,787 patients underwent EGD; 219 patients (1.3%) were labeled as having ESEM. Only 41 patients had biopsyproven BE (18.7% of ESEM and 0.24% of total patients). The mean age of the patients with BE was 58.1 years [Standard deviation (SD) =13.7] and 78% were men. Of the 41 patients, 14 (34.1%) had long-segment BE (LSBE) (>3 cm) while 27 had short segment Barrett s Esophagus (SSBE) (≤3 cm). Hiatal hernia was identified in 54% of the patients, more commonly in those with LSBE. Only four patients had low-grade dysplasia, and none had high-grade dysplasia. Conclusion: The prevalence of BE in Lebanon is much lower than that in Western countries. The reasons for this East-West divide are unknown and require further investigation.

🔖

Cite This Article

MASRİ, O., İBRAHİM, F., BADREDDİNE, R., SHARARA, A., CHALHOUB, J. (2022). Prevalence of Barrett's esophagus in Lebanon. Turkish Journal of Gastroenterology, Cilt: 26 - Sayı: 3, 214–217. https://ajindex.com/articles/606232

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R, Global Consen- sus Group. The Montreal definition and classification of gastro- esophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006; 101: 1900-20. [CrossRef] Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ, Ameri- can Gastroenterological Association. American Gastroenterologi- cal Association technical review on the management of Barrett’s esophagus. Gastroenterology 2011; 140: e18-52. [CrossRef] Weston AP, Badr AS, Hassanein RS. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the de- velopment of Barrett’s multifocal high-grade dysplasia or adeno- carcinoma. Am J Gastroenterol 1999; 94: 3413-9. [CrossRef] Khandwalla HE, Graham DY, Kramer JR, et al. Barrett’s esophagus sus- pected at endoscopy but no specialized intestinal metaplasia on bi- opsy, what’s next? Am J Gastroenterol. 2014; 109: 178-82. [CrossRef] Ronkainen J, Aro P, Storskrubb T, et al. Prevalence of Barrett’s esophagus in the general population: an endoscopic study. Gas- troenterology 2005; 129: 1825-31. [CrossRef] Conio M, Lapertosa G, Blanchi S, Filiberti R. Barrett’s esophagus: an update. Crit Rev Oncol Hematol 2003; 46: 187-206. [CrossRef] 7. Zagari RM, Fuccio L, Wallander MA, et al. Gastro-oesophageal reflux symptoms, oesophagitis and Barrett’s oesophagus in the general population: the Loiano-Monghidoro study. Gut 2008; 57: 1354-9. [CrossRef] 8. Zou D, He J, Ma X, et al. Epidemiology of symptom-defined gastroesophageal reflux disease and reflux esophagitis: the sys- tematic investigation of gastrointestinal diseases in China (SILC). Scand J Gastroentero 2011; 46: 133-41. [CrossRef] 9. Rex DK, Cummings OW, Shaw M, et al. Screening for Barrett’s esophagus in colonoscopy patients with and without heartburn. Gastroenterology 2003; 125: 1670-7. [CrossRef] 10. Gadour MO, Ayoola EA. Barrett’s oesophagus and oesophageal cancer in Saudi Arabia. Trop Gastroenterol 1999; 20: 111-5. 11. Fireman Z, Wagner G, Weissman J, et al. Prevalence of short-seg- ment Barrett’s epithelium. Dig Liver Dis 2001; 33: 322-5. [CrossRef] 12. Nasseri-Moghaddam S, Malekzadeh R, Sotoudeh M, et al. Lower esophagus in dyspeptic Iranian patients: a prospective study. J Gastroenterol Hepatol 2003; 18: 315-21. [CrossRef] 13. Ahmed HH, Mudawi HM, Fedail SS. Gastro-oesophageal reflux disease in Sudan: a clinical endoscopic and histopathological study. Trop Gastroenterol 2004; 25: 135-8.